pepJIP1

Pamapimod : Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

SC144 :Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells

MALT1 inhibitor : Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease

Bicalutamide : Bicalutamide causes heart failure in an elderly patient with prostate cancer

Ponatinib : Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma